Agios
Since our founding, Agios has been a pioneering leader in cellular metabolism, advancing therapies for patients with unmet needs. …
About Us - Agios
Agios was founded in 2008 to unlock a new field of discovery in cellular metabolism. This singular focus on metabolic disease has …
Agios Pharmaceuticals - Wikipedia
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined …
Agios Pharmaceuticals - LinkedIn
Fueled by Connections to Transform Rare Diseases™ | Agios is a commercial-stage biopharmaceutical company dedicated to …
Here's Why Agios Pharmaceuticals Stock Soared Today (Hint: It's FDA ...
Jul 7, 2026 · Here's Why Agios Pharmaceuticals Stock Soared Today (Hint: It's FDA-Related) The company received some good …
Agios Pharmaceuticals, Inc. (AGIO) - Yahoo Finance
Find the latest Agios Pharmaceuticals, Inc. (AGIO) stock quote, history, news and other vital information to help you with your stock …
Agios Pharmaceuticals (AGIO) Stock Price & Overview
9 hours ago · A detailed overview of Agios Pharmaceuticals, Inc. (AGIO) stock, including real-time price, chart, key statistics, news, …
Agios’ Pyrukynd turns in mixed results in sickle cell ph. 3
Nov 19, 2025 · Agios’ shares nosedived by 49% on Wednesday morning after the company revealed mixed phase 3 results for …
Agios shares slump on sickle cell disease data | pharmaphorum
2 days ago · Agios' positive assessment of the SCD data did not stop some investors from losing their nerve, however, and Agios' …
Agios Pharmaceuticals (AGIO) Is Up 5.4% After Mixed 2025 Results …
Feb 14, 2026 · We'll now examine how the earnings beat, powered by stronger-than-expected product revenue, may reshape Agios …